Disease
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is a Phase 1 registry record with no posted results; it describes a planned single-dose interventional study in a small sample (n=40) using surrogate endpoints (affect, pain catastrophizing, quantitative sensory testing) to explore mechanistic effects of psilocybin in a novel indication.
AUG 20, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a clinical trial registry record describing a planned study with no results posted; enrollment is ongoing and primary outcomes at 12 months have not yet been reported.